Movement Alert｜Moderna, Inc. Intraday Rise 3.02% in Regular Trading, Nasdaq 100 Inclusion Boosts Market Position
Market Focus
Oct 05
On October 5, Moderna, Inc. rose 3.02% in Regular Trading to $195.78 per share with turnover of $9.55 billion.
The uptick follows Nasdaq's announcement that Moderna will replace Warner Bros Discovery in the Nasdaq 100 Index effective October 9, which is expected to drive passive fund inflows and increase market visibility.
Currently transitioning from its COVID-19 vaccine success, Moderna is advancing tumor vaccine commercialization and scaling production for five approved infectious disease vaccines.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.